Follicle dynamics and anovulation in polycystic ovary syndrome
Open accessThe DOI matches its Crossref record; 129 of the 130 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Polycystic ovary syndrome (PCOS) is the commonest cause of anovulatory infertility and menstrual cycle abnormalities, but the factors responsible for failure to select a dominant follicle remain unclear. METHOD: Source is authors' own studies and search of the relevant literature. RESULTS: Arrest of antral follicle growth is associated with an abnormal endocrine environment involving hypersecretion of luteinizing hormone and insulin (and perhaps hyperandrogenism). The net effect is secondary suppression of FSH, which leads to inhibition of maturation of otherwise healthy follicles in the cohort. There is, however, emerging evidence for an intrinsic abnormality of folliculogenesis in PCOS that affects the very earliest, gonadotrophin independent, stages of follicle development. There is an increased density of small pre-antral follicles and an increased proportion of early growing follicles. These abnormalities in anovulatory PCOS are further defined by abnormal granulosa cell proliferation and disparate growth of oocyte and surrounding granulosa cells. This suggests that the normal 'dialogue' between oocyte and granulosa cells in these early growing follicles is altered. There is evidence that abnormal, local (follicle-to-follicle) signalling of anti-Müllerian hormone may play a part in disordered folliculogenesis, but it is plausible that other local regulators that have been implicated in normal and abnormal pre-antral follicle development-such as insulin-like growth factors and sex steroids-have a role in aberrant folliculogenesis in PCOS. CONCLUSIONS: Significant abnormalities in the very earliest stages of folliculogenesis may be the root cause of anovulation in PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is well established that the apoptosis-induced follicular atresia of the granulosa cells (GCs) is also a key component of the failure in the dominant follicle selection [41].”
From Liraglutide and polycystic ovary syndrome: is it only a matter of body weight? (2023) · cites this paper as [41]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yildiz, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,712
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Self-citationInsulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
Dunaif, A. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,458
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Ehrmann, D. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041536 · Cited by 1,881
Knochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,516
Regulation of ovarian follicular development in primates: facts and hypotheses
GOUGEON, A. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-2-121 · Cited by 1,497
Asunción, M., Calvo, R. M., San Millán, J. L., Sancho, J., Avila, S., & Escobar-Morreale, H. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6682 · Cited by 1,318
Cited by
Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020
Franks, S. (1997) · Archives of Disease in Childhood · doi:10.1136/adc.77.1.89 · Cited by 806
Self-citationObesity and polycystic ovary syndrome
Barber, T. M., McCarthy, M. I., Wass, J. A. H., & Franks, S. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02587.x · Cited by 631
Self-citationDewailly, D., Robin, G., Peigne, M., Decanter, C., Pigny, P., & Catteau-Jonard, S. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw027 · Cited by 526
Genetic, hormonal and metabolic aspects of PCOS: an update
De Leo, V., Musacchio, M. C., Cappelli, V., Massaro, M. G., Morgante, G., & Petraglia, F. (2016) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-016-0173-x · Cited by 484
“named kisspeptin receptor or Kiss1R [64, 65, 68].”
BackgroundInfluentialQiao, J., & Feng, H. L. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq032 · Cited by 479
Hayes, M. G., Urbanek, M., Ehrmann, D. A., Armstrong, L. L., Lee, J. Y., Sisk, R., Karaderi, T., Barber, T. M., McCarthy, M. I., Franks, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms8502 · Cited by 478
Self-citationIbáñez, L., Oberfield, S. E., Witchel, S., Auchus, R. J., Chang, R. J., Codner, E., Dabadghao, P., Darendeliler, F., Elbarbary, N. S., Gambineri, A., et al. (2017) · Hormone Research in Paediatrics · doi:10.1159/000479371 · Cited by 463
Cimino, I., Casoni, F., Liu, X., Messina, A., Parkash, J., Jamin, S. P., Catteau-Jonard, S., Collier, F., Baroncini, M., Dewailly, D., et al. (2016) · Nature Communications · doi:10.1038/ncomms10055 · Cited by 404
Obesity and polycystic ovary syndrome
Barber, T. M., & Franks, S. (2021) · Clinical Endocrinology · doi:10.1111/cen.14421 · Cited by 385
Self-citationGenetic Basis of Polycystic Ovary Syndrome (PCOS): Current Perspectives
Khan, M. J., Ullah, A., & Basit, S. (2019) · The Application of Clinical Genetics · doi:10.2147/tacg.s200341 · Cited by 354
Ovulation induction in the management of anovulatory polycystic ovary syndrome
Balen, A. H. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.10.008 · Cited by 347
Caldwell, A. S. L., Middleton, L. J., Jimenez, M., Desai, R., McMahon, A. C., Allan, C. M., Handelsman, D. J., & Walters, K. A. (2014) · Endocrinology · doi:10.1210/en.2014-1196 · Cited by 342
Autophagy in ovary and polycystic ovary syndrome: role, dispute and future perspective
Kumariya, S., Ubba, V., Jha, R. K., & Gayen, J. R. (2021) · Autophagy · doi:10.1080/15548627.2021.1938914 · Cited by 305
Deconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification
Dapas, M., & Dunaif, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac001 · Cited by 300
Xu, Y., & Qiao, J. (2022) · Journal of Healthcare Engineering · doi:10.1155/2022/9240569 · Cited by 283
Chang, H.-M., Qiao, J., & Leung, P. C. K. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw039 · Cited by 265
Insulin and the polycystic ovary syndrome
Macut, D., Bjekić-Macut, J., Rahelić, D., & Doknić, M. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.06.011 · Cited by 261
Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype
McAllister, J. M., Modi, B., Miller, B. A., Biegler, J., Bruggeman, R., Legro, R. S., & Strauss, J. F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400574111 · Cited by 250
Monniaux, D., Clément, F., Dalbiès-Tran, R., Estienne, A., Fabre, S., Mansanet, C., & Monget, P. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.113.117077 · Cited by 233
Insulin signalling and glucose transport in the ovary and ovarian function during the ovarian cycle
Dupont, J., & Scaramuzzi, R. J. (2016) · Biochemical Journal · doi:10.1042/bcj20160124 · Cited by 231
Wang, D., Weng, Y., Zhang, Y., Wang, R., Wang, T., Zhou, J., Shen, S., Wang, H., & Wang, Y. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.141049 · Cited by 229
The management of patients with polycystic ovary syndrome
Jayasena, C. N., & Franks, S. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.102 · Cited by 196
Self-citationPolycystic Ovary Syndrome (PCOS), Diagnostic Criteria, and AMH
Banimohammad, M., & Seghinsara, A. M. (2017) · PubMed · doi:10.22034/apjcp.2017.18.1.17 · Cited by 192
Polycystic ovary syndrome as a metabolic disease
Helvaci, N., & Yildiz, B. O. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01057-w · Cited by 188
PCOS Forum: research in polycystic ovary syndrome today and tomorrow: Forum in PCOS research
Pasquali, R., Stener-Victorin, E., Yildiz, B. O., Duleba, A. J., Hoeger, K., Mason, H., Homburg, R., Hickey, T., Franks, S., Tapanainen, J. S., et al. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03956.x · Cited by 185
Self-citationCalcaterra, V., Verduci, E., Cena, H., Magenes, V. C., Todisco, C. F., Tenuta, E., Gregorio, C., De Giuseppe, R., Bosetti, A., Di Profio, E., et al. (2021) · Nutrients · doi:10.3390/nu13061848 · Cited by 183
Insulin-Like Growth Factor-I is a Marker for the Nutritional State.
Hawkes, C. P., & Grimberg, A. (2015) · PubMed · Cited by 182
Progesterone Actions and Resistance in Gynecological Disorders
MacLean, J. A., & Hayashi, K. (2022) · Cells · doi:10.3390/cells11040647 · Cited by 176
Estienne, A., Bongrani, A., Reverchon, M., Ramé, C., Ducluzeau, P.-H., Froment, P., & Dupont, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184431 · Cited by 173
Barber, T. M., Kyrou, I., Randeva, H. S., & Weickert, M. O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020546 · Cited by 169
Role of androgens in normal and pathological ovarian function
Walters, K. A. (2015) · Reproduction · doi:10.1530/rep-14-0517 · Cited by 166
Involvement of androgens in ovarian health and disease
Lebbe, M., & Woodruff, T. K. (2013) · Molecular Human Reproduction · doi:10.1093/molehr/gat065 · Cited by 165
Wang, T., Sha, L., Li, Y., Zhu, L., Wang, Z., Li, K., Lu, H., Bao, T., Guo, L., Zhang, X., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00284 · Cited by 162
“Furthermore, the suppressed FSH results in the arrest of ovarian folliculogenesis and corpora lutea under the synergistic effect of LH, thereby decreasing the PROG produced by the corpus luteum (60).”
BackgroundGleicher, N., Weghofer, A., & Barad, D. H. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-116 · Cited by 162
Novel Role of the SIRT1 in Endocrine and Metabolic Diseases
Lu, C., Zhao, H., Liu, Y., Yang, Z., Yao, H., Liu, T., Gou, T., Wang, L., Zhang, J., Tian, Y., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.78654 · Cited by 160
“This may be the result of hypothalamo-pituitary ovarian axis disorder, follicular membrane cells or granulosa cells (GC) dysfunction, and metabolic abnormalities [121-123].”
Campbell, B. K., Clinton, M., & WEBB, R. (2012) · Endocrinology · doi:10.1210/en.2012-1158 · Cited by 156
Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach
Toosy, S., Sodi, R., & Pappachan, J. M. (2018) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-018-0371-5 · Cited by 154
Polycystic Ovary Syndrome: Effect and Mechanisms of Acupuncture for Ovulation Induction
Johansson, J., & Stener‐Victorin, E. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/762615 · Cited by 150
Inositol in Polycystic Ovary Syndrome: Restoring Fertility through a Pathophysiology-Based Approach
Laganà, A. S., Garzon, S., Casarin, J., Franchi, M., & Ghezzi, F. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.09.001 · Cited by 149
Xiang, Y., Wang, H., Ding, H., Xu, T., Liu, X., Huang, Z., Wu, H., & Ge, H. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111141 · Cited by 142
Chauvin, S., Cohen-Tannoudji, J., & Guigon, C. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010512 · Cited by 137
Paixão, L., Ramos, R. B., Lavarda, A., Morsch, D. M., & Spritzer, P. M. (2017) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-017-0231-z · Cited by 136
Immunological and Metabolic Causes of Infertility in Polycystic Ovary Syndrome
Kicińska, A. M., Maksym, R., Zabielska-Kaczorowska, M. A., Stachowska, A., & Babińska, A. (2023) · Biomedicines · doi:10.3390/biomedicines11061567 · Cited by 135
Androgen circle of polycystic ovary syndrome
Homburg, R. (2009) · Human Reproduction · doi:10.1093/humrep/dep049 · Cited by 134
Pierre, A., Peigné, M., Grynberg, M., Arouche, N., Taieb, J., Hesters, L., Gonzales, J., Picard, J., Dewailly, D., Fanchin, R. R. F., et al. (2013) · Human Reproduction · doi:10.1093/humrep/des460 · Cited by 133
Franks, S. (2013) · Medicine · doi:10.1016/j.mpmed.2013.07.015 · Cited by 130
Self-citationHudecova, M., Holte, J., Olovsson, M., & Sundstrom Poromaa, I. (2009) · Human Reproduction · doi:10.1093/humrep/den482 · Cited by 127
Sagvekar, P., Kumar, P., Mangoli, V. S., Desai, S. K., & Mukherjee, S. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0657-6 · Cited by 125
Ontogeny of the ovary in polycystic ovary syndrome
Dumesic, D. A., & Richards, J. S. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.02.011 · Cited by 120
Veiga-Lopez, A., Steckler, T. L., Abbott, D. H., Welch, K. B., MohanKumar, P. S., Phillips, D. J., Refsal, K., & Padmanabhan, V. (2011) · Biology of Reproduction · doi:10.1095/biolreprod.110.086686 · Cited by 118
Ernst, E., Grøndahl, M. L., Grund, S., Hardy, K., Heuck, A., Sunde, L., Franks, S., Andersen, C. Y., Villesen, P., & Lykke‐Hartmann, K. (2017) · Human Reproduction · doi:10.1093/humrep/dex238 · Cited by 118
Self-citationAntiepileptic drugs, sex hormones, and PCOS
Verrotti, A., D’Egidio, C., Mohn, A., Coppola, G., Parisi, P., & Chiarelli, F. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2010.02897.x · Cited by 117
Circulating microRNAs in follicular fluid, powerful tools to explore in vitro fertilization process
Scalici, E., Traver, S., Mullet, T., Molinari, N., Ferrières, A., Brunet, C., Belloc, S., & Hamamah, S. (2016) · Scientific Reports · doi:10.1038/srep24976 · Cited by 117
Duică, F., Dănilă, C. A., Boboc, A. E., Antoniadis, P., Condrat, C. E., Onciul, S., Suciu, N., Creţoiu, S. M., Varlas, V. N., & Crețoiu, D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.614679 · Cited by 114
Geng, X., Zhao, J., Huang, J., Li, S., Chu, W., Wang, W., Chen, Z., & Du, Y. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.11.018 · Cited by 114
Franks, S., & Hardy, K. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00452 · Cited by 109
“The mechanism of follicle arrest is complex but is likely to be due to the abnormal endocrine environment that includes excessive secretion of LH, insulin and androgens, all of which may contribute to premature arrest of follicles (1, 50, 51).”
BackgroundSelf-citationvan Houten, E. L. A. F., & Visser, J. A. (2013) · Reproductive Biology · doi:10.1016/j.repbio.2013.09.007 · Cited by 109
Reappraising the relationship between hyperinsulinemia and insulin resistance in PCOS
Houston, E. J., & Templeman, N. M. (2025) · Journal of Endocrinology · doi:10.1530/joe-24-0269 · Cited by 109
Nonhuman primate models of polycystic ovary syndrome
Abbott, D. H., Nicol, L. E., Levine, J. E., Xu, N., Goodarzi, M. O., & Dumesic, D. A. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.01.013 · Cited by 107
Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome
Dewailly, D., Barbotin, A.-L., Dumont, A., Catteau-Jonard, S., & Robin, G. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00641 · Cited by 104
Impact of PCOS on early embryo cleavage kinetics
Wissing, M. L., Bjerge, M. R., Olesen, A. I. G., Hoest, T., & Mikkelsen, A. L. (2013) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2013.11.017 · Cited by 103
Haqq, L., McFarlane, J., Dieberg, G., & Smart, N. (2014) · Endocrine Connections · doi:10.1530/ec-14-0010 · Cited by 101
Palomba, S., Falbo, A. I., Carrillo, L. I. V., Villani, M. T., Orio, F., Russo, T., Cello, A. D., Cappiello, F., Capasso, S., Tolino, A., et al. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.020 · Cited by 101
Neuroendocrine Determinants of Polycystic Ovary Syndrome
Szeliga, A., Rudnicka, E., Maciejewska-Jeske, M., Kucharski, M., Kostrzak, A., Hajbos, M., Niwczyk, O., Smolarczyk, R., & Męczekalski, B. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19053089 · Cited by 101
Polycystic Ovarian Syndrome: A Complex Disease with a Genetics Approach
Nautiyal, H., Imam, S. S., Alshehri, S., Ghoneim, M. M., Afzal, M., Alzarea, S. I., Güven, E., Al-Abbasi, F. A., & Kazmi, I. A. (2022) · Biomedicines · doi:10.3390/biomedicines10030540 · Cited by 100
Anti-Müllerian hormone and polycystic ovary syndrome
Bhide, P., & Homburg, R. (2016) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.03.004 · Cited by 100
Serum AMH levels and insulin resistance in women with PCOS
Şahmay, S., Mathyk, B. A., Sofiyeva, N., Atakul, N., Azemi, A., & Erel, C. T. (2018) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2018.03.007 · Cited by 100
The role of IGF1 in the in vivo production of bovine embryos from superovulated donors
Velazquez, M. A., Zaraza, J., Oropeza, A., WEBB, R., & Niemann, H. (2009) · Reproduction · doi:10.1530/rep-08-0362 · Cited by 98
Disordered follicle development
Chang, R. J., & Cook-Andersen, H. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.07.011 · Cited by 97
FOXO1/3 Depletion in Granulosa Cells Alters Follicle Growth, Death and Regulation of Pituitary FSH
Liu, Z., Castrillon, D. H., Zhou, W., & Richards, J. S. (2013) · Molecular Endocrinology · doi:10.1210/me.2012-1296 · Cited by 97
Impaired receptivity and decidualization in DHEA-induced PCOS mice
Li, S., Song, Z., Song, M., Qin, J., Zhao, M.-L., & Yang, Z. (2016) · Scientific Reports · doi:10.1038/srep38134 · Cited by 97
Li, W., Liu, C., Yang, Q., Zhou, Y., Liu, M., & Shan, H. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1018674 · Cited by 95
Facchinetti, F., Orrù, B., Grandi, G., & Unfer, V. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1540578 · Cited by 94
“The increased androgen signaling causes premature follicular atresia and anovulation [1, 3].”
BackgroundEndometrial Abnormality in Women With Polycystic Ovary Syndrome
Shang, K., Jia, X., Qiao, J., Kang, J., & Guan, Y. (2012) · Reproductive Sciences · doi:10.1177/1933719111430993 · Cited by 93
Azhary, J. M. K., Harada, M., Takahashi, N., Nose, E., Kunitomi, C., Koike, H., Hirata, T., Hirota, Y., Koga, K., Wada‐Hiraike, O., et al. (2018) · Endocrinology · doi:10.1210/en.2018-00675 · Cited by 93
Genetics of Polycystic Ovary Syndrome
Barber, T. M., & Franks, S. (2013) · Frontiers of Hormone Research · doi:10.1159/000341682 · Cited by 92
Self-citationEndometriosis and polycystic ovary syndrome are diametric disorders
Dinsdale, N. L., & Crespi, B. J. (2021) · Evolutionary Applications · doi:10.1111/eva.13244 · Cited by 90
“Low FSH and epigenetic changes in regulatory regions of the aromatase gene CYP19A1 are associated with the aromatase deficiency and androgen excess in PCOS (Franks et al., 2008).”
BackgroundObesity-Related Hypogonadism in Women
Eng, P. C., Phylactou, M., Qayum, A., Woods, C., Lee, H., Aziz, S., Moore, B., Miras, A. D., Comninos, A. N., Tan, T., et al. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad027 · Cited by 90
Self-citationBongrani, A., Mellouk, N., Ramé, C., Cornuau, M., Guérif, F., Froment, P., & Dupont, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153778 · Cited by 89
Perspectives in polycystic ovary syndrome: From hair to eternity
Dunaif, A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3780 · Cited by 87
Metformin: The hidden chronicles of a magic drug
Mahmood, K., Naeem, M., & Rahimnajjad, N. A. (2012) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2012.10.011 · Cited by 87
Chang, E. M., Han, J. E., Seok, H. H., Lee, D. R., Yoon, T. K., & Lee, W. S. (2013) · Clinical Endocrinology · doi:10.1111/cen.12099 · Cited by 86
Owens, L. A., Kristensen, S. G., Lerner, A., Christopoulos, G., Lavery, S., Hanyaloglu, A. C., Hardy, K., Yding Andersen, C., & Franks, S. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00780 · Cited by 85
“Insulin can stimulate GC steroidogenesis and enhance GC responsiveness to LH (33), and increased androgen synthesis may augment FSH receptor signaling, both of which may increase local production of cyclic AMP and encourage terminal differentiation of GCs (8).”
BackgroundSelf-citationDiagnosis and Management of Polycystic Ovary Syndrome in Adolescents
Trent, M., & Gordon, C. M. (2020) · PEDIATRICS · doi:10.1542/peds.2019-2056j · Cited by 84
Polycystic Ovarian Syndrome: Role of Imaging in Diagnosis
Lee, T. T., & Rausch, M. E. (2012) · Radiographics · doi:10.1148/rg.326125503 · Cited by 84
Hosseini, E., Shahhoseini, M., Afsharian, P., Karimian, L., Ashrafi, M., Mehraein, F., & Afatoonian, R. (2019) · Archives of Medical Science · doi:10.5114/aoms.2019.86060 · Cited by 82
Ndeingang, E. C., Deeh, P. B. D., Watcho, P., & Kamanyi, A. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/2965821 · Cited by 81
Abramovich, D., Irusta, G., Bas, D., Cataldi, N. I., Parborell, F., & Tesone, M. (2012) · Endocrinology · doi:10.1210/en.2012-1105 · Cited by 80
Tan, M., Cheng, Y., Zhong, X., Yang, D., Jiang, S., Ye, Y., Ding, M., Guan, G., Yang, D., & Zhao, X. (2021) · Aging · doi:10.18632/aging.202421 · Cited by 78
Gao, Y., Chen, J., Ji, R., Ding, J., Zhang, Y., & Yang, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.779718 · Cited by 77
The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum
Rosenfield, R. L. (2015) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2014.07.016 · Cited by 76
Pathophysiology of Polycystic Ovary Syndrome: The Role of Hyperandrogenism
Catteau-Jonard, S., & Dewailly, D. (2013) · Frontiers of Hormone Research · doi:10.1159/000341679 · Cited by 76
Solano, M. E., Sander, V. A., Ho, H., Motta, A. B., & Arck, P. (2011) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2011.09.003 · Cited by 76
Yang, H. J., Kim, H. J., Pyun, B., & Lee, H. W. (2018) · Integrative Medicine Research · doi:10.1016/j.imr.2018.05.003 · Cited by 76
Huang, J., Chen, P., Xiang, Y., Liang, Q., Wu, T., Liu, J., Zeng, Y., Zeng, H., Liang, X., & Zhou, C. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108717 · Cited by 76
Polycystic Ovary-Like Abnormalities (PCO-L) in Women with Functional Hypothalamic Amenorrhea
Robin, G., Gallo, C., Catteau-Jonard, S., Maunoury-Lefebvre, C., Pigny, P., Duhamel, A., & Dewailly, D. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1836 · Cited by 75
Metadata
- Authors
- Franks, S., Stark, J., & Hardy, K.
- Affiliations
- Hammersmith Hospital (GB)
- Imperial College London (GB)
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-04-02
- Volume
- 14
- Issue
- 4
- Pages
- 367-378
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W2125717115
- Cited by
- 581
- References
- 130
- Citations by year
- 2026: 27 · 2025: 44 · 2024: 39 · 2023: 52 · 2022: 48 · 2021: 40 · 2020: 41 · 2019: 35 · 2018: 28 · 2017: 24 · 2016: 32 · 2015: 32 · 2014: 24 · 2013: 36 · 2012: 32
- FWCI
- 2.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Human Reproduction Update (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- polycystic ovary syndrome, anovulation, folliculogenesis, dominant follicle selection, insulin resistance, FSH suppression, preantral follicles, granulosa cell proliferation, oocyte-granulosa cell communication, anti-Müllerian hormone, insulin-like growth factor, sex steroids, anovulatory infertility
- MeSH terms
- Anovulation, Female, Ovarian Follicle, Humans, Insulin Resistance, Models, Biological, Oocytes, Polycystic Ovary Syndrome, Gonadal Steroid Hormones, Somatomedins, Signal Transduction, Cell Proliferation, Anti-Mullerian Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.